Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of ketotifen and
indomethacin taken together to improve symptoms related with COVID-19. Ketotifen and
indomethacin are medications approved by the Food and Drug Administration (FDA) to treat
diseases other than COVID-19. Their use in this study is investigational, meaning they have
not been approved by the FDA to treat COVID-19.